Model
Edge
Eliem Therapeutics
0001867539
Filing Type
4
Filing Date
5/31/2022
Updated
6/1/22, 11:07 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership